About this trial
We will investigate the clinical manifestations and molecular genetic defects of heritable urologic malignant disorders. Families with urologic malignancy with known or suspected genetic basis will be enrolled. Affected individuals or individuals suspected of having a germline urologic malignant disorder will undergo periodic clinical assessment and genetic analyses for the purpose of: 1) definition and characterization of phenotype, 2) determination of the natural history of the disorder, and 3) genotype/phenotype correlation. Genetic linkage studies may be performed in situations in which the genetic basis of the disorder has not been elucidated.
...
Eligibility criteria
Qualifiers
One or more histologically proven or suspected renal carcinomas and/or cysts
Cerebellar, spinal, medullary or cerebral hemangioblastomas
Retinal angioma
Pancreatic neuro-endocrine carcinoma,micro cystadenoma and/or cysts
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed